The emerging market for Parkinson’s tech

When my father was diagnosed with Parkinson’s disease decades ago, the news came too late for early intervention. Today, while we’re not any closer to curing the disease, we are getting better at early detection. Researchers are developing several noninvasive tools that monitor everything from breath to handwriting to keystrokes, to flag the disease before clinical symptoms manifest. SN‘s Meghan Rosen delivers the good news.

🫆 Decoding the biological fingerprint

Traditionally, Parkinson’s is identified only after hallmark motor symptoms — such as resting tremors, muscle rigidity or gait disturbances — have become clinically evident. Unfortunately, this often delays intervention until significant neurological damage has already occurred. To close this gap, researchers are pioneering noninvasive, high-sensitivity diagnostic tools that even nonspecialists could use to capture the “invisible” signatures of early-stage neurodegeneration. Here are a few of the diagnostic techniques in the works:

• Magnetoelastic sensors: The slightest touch or squeeze to a special soft ball distorts its magnetic layer and generates measurable electrical signals, to precisely quantify even minute, involuntary tremors.
  
• Smart pen technology: The same mechanism underpins a pen equipped with a deformable magnetic tip and iron-containing magnetic liquid. It records signals from a patient’s writing in real time, and software can detect the specific, subtle loss of fluidity that often precedes clinical motor decline.
  
• Intelligent typing interfaces: The same so-called magnetoelastic effect can be harnessed for pressure-sensitive, sweatproof keyboards that log subtle metrics such as the length of time a subject presses the keys or pauses between keystrokes, capturing how fine motor control degrades during digital interactions.